Hyperinsulinemia in polycystic ovary disease

Area of Science:

• Endocrinology
• Reproductive Medicine
• Metabolic Disorders

Background:

• Polycystic Ovary Disease (PCOD) is a common endocrine disorder.
• Insulin resistance and hyperinsulinemia are increasingly recognized in PCOD.
• Understanding their prevalence is crucial for effective management.

Purpose of the Study:

• To determine the prevalence of hyperinsulinemia and insulin resistance in women diagnosed with PCOD.
• To investigate potential clinical associations with these metabolic abnormalities.

Main Methods:

• Prospective study of 40 women with PCOD and 20 controls with regular cycles.
• All participants underwent a 3-hour oral glucose tolerance test (OGTT) with a 100g glucose load.
• Plasma glucose and insulin levels were measured at multiple time points during the OGTT.

Main Results:

• Women with PCOD exhibited significantly higher insulin levels at 1, 2, and 3 hours post-glucose load compared to controls.
• Key markers of insulin response, including sum insulin, cumulative insulin, peak insulin, and area under the insulin response curve, were elevated in the PCOD group.
• Hyperinsulinemia and insulin resistance were more frequently observed in women with hirsutism, but not significantly associated with body mass index or menstrual irregularity.

Conclusions:

• Hyperinsulinemia and insulin resistance are highly prevalent in women with polycystic ovary disease.
• These metabolic derangements appear common in PCOD, suggesting a significant role in the pathophysiology.
• Hirsutism may serve as a clinical indicator associated with these findings in PCOD patients.